Sharath Vipparthy, MD
Clinical Cardiac Electrophysiology · Indianapolis, INNPI 1588005078
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (42.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Medtronic at 47.1% of the total. Reporting peaked in 2022 at $43,686 and has fallen 50.7% since, to $21,520 in 2025. Among clinical cardiac electrophysiology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 562 payments — averaging $203.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$54K
- Boston Scientific$23K
- Abbott$19K
- Biotronik Inc.$11K
- Medical Device Business Services, Inc.$3K
- Cardiofocus, Inc.$968
- plus $4K from 14 others
What the payments were for
- Grants$48,24642%
- Travel & lodging$39,27134%
- Food & beverage$25,75223%
- Education$9461%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 233 | $53,808 |
| Boston Scientific | 54 | $23,206 |
| Abbott | 145 | $18,644 |
| Biotronik Inc. | 65 | $11,458 |
| Medical Device Business Services, Inc. | 7 | $2,537 |
| Cardiofocus, Inc. | 8 | $968 |
| Abiomed | 3 | $883 |
| Biosense Webster, Inc. | 17 | $689 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $451 |
| Baylis Medical Company Inc | 2 | $400 |
| Philips North America LLC | 2 | $351 |
| Johnson & Johnson | 3 | $338 |
| Cook Incorporated | 1 | $141 |
| Boehringer Ingelheim | 1 | $125 |
| Bayer | 1 | $63 |
| Novo Nordisk | 2 | $49 |
| Cook Medical LLC | 1 | $45 |
| Pfizer | 2 | $32 |
| Getinge USA Sales, LLC | 1 | $16 |
| Cvrx, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$7,500
- EMBLEM MRI S-ICD$7,500
- ENSITE$7,170
- ENSITE PRECISION$4,426
- Solia$4,101
- Edora 8 DR-T$3,987
- Acticor 7 VR-T DX$3,987
- BioMonitor$3,430
- Rivacor 7 DR-T$3,029
- Carto 3$2,699
- AVEIR$2,380
- Micra$1,405
- WATCHMAN Access System$1,295
- GENERAL - THERAPIES$1,278
- GENERAL - STRUCTURAL$1,105
- Plexa ProMRI$958
- Sentus$958
- Impella$883
- HeartLight System$868
- EnSite Precision Cardiac Mapping System$614
How this compares
$114,215 in reported general payments places this provider in the 95th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
See all clinical cardiac electrophysiology providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 292 | $187,569 |
| XareltoRivaroxaban | 50 | $30,373 |
| EntrestoSacubitril/Valsartan | 16 | $15,485 |
| Amiodarone Hcl | 156 | $1,734 |
| Metoprolol Succinate | 120 | $1,646 |
| Mupirocin | 68 | $522 |
| Metoprolol Tartrate | 71 | $403 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 15 | $236 |
| Carvedilol | 38 | $209 |
| Losartan Potassium | 17 | $180 |
| Amlodipine Besylate | 19 | $118 |
| Warfarin Sodium | 16 | $113 |
| Atorvastatin Calcium | 13 | $108 |
| Furosemide | 22 | $38 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $32 | $187,569292 claims |
| Johnson & JohnsonXarelto | $338 | $30,37350 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
Other clinical cardiac electrophysiology in Indianapolis
- Eric PrystowskyIndianapolis$1.1M
- Kevin TrulockIndianapolis$402K
- Jasen GilgeIndianapolis$93K
- Vincent KeatingIndianapolis$80K
- Christopher ReedIndianapolis$80K
- Marcelle StuckyIndianapolis$76K
- Joseph SzwedIndianapolis$67K
- Krishna MalineniIndianapolis$65K
- Anil PurohitIndianapolis$45K
- Bradley ClarkIndianapolis$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.